UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2010-03, Vol.13 (1), p.1-10

2010

Link zum Volltext

Verfügbarkeit prüfen

Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer

Journal of medicinal chemistry, 2021-12, Vol.64 (24), p.18114-18142

2021

Link zum Volltext

Verfügbarkeit prüfen

E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.2050-2056

2009

Link zum Volltext

Verfügbarkeit prüfen

A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells

Scientific reports, 2019-08, Vol.9 (1), p.12511-15, Article 12511

2019

Link zum Volltext

Verfügbarkeit prüfen

A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria

The Journal of urology, 2012-09, Vol.188 (3), p.741

2012

Link zum Volltext

Verfügbarkeit prüfen

Hereditary gastric cancer: what’s new? Update 2013–2018

Familial cancer, 2019-07, Vol.18 (3), p.363-367

2019

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer

BMC cancer, 2017-03, Vol.17 (1), p.228-228, Article 228

2017

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation

Journal of biomolecular screening, 2015-12, Vol.20 (10), p.1286-1293

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma

Urologic oncology, 2017-08, Vol.35 (8), p.531.e15-531.e22

2017

Link zum Volltext

Verfügbarkeit prüfen

Modelling hereditary diffuse gastric cancer initiation using transgenic mouse‐derived gastric organoids and single‐cell sequencing

The Journal of pathology, 2021-07, Vol.254 (3), p.254-264

2021

Link zum Volltext

Verfügbarkeit prüfen

E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-03, Vol.22 (2), p.273-286

2019

Link zum Volltext

Verfügbarkeit prüfen

E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors

Cancers, 2021-12, Vol.14 (1), p.175

2021

Link zum Volltext

Verfügbarkeit prüfen

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

Gastroenterology (New York, N.Y. 1943), 2001-12, Vol.121 (6), p.1348-1353

2001

Link zum Volltext

Verfügbarkeit prüfen

Cohesin mutations are synthetic lethal with stimulation of WNT signaling

eLife, 2020-12, Vol.9

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Roche Cell-Free DNA collection Tubes® to Streck Cell-Free DNA BCT®s for sample stability using healthy volunteers

Practical laboratory medicine, 2019-08, Vol.16, p.e00125-e00125, Article e00125

2019

Link zum Volltext

Verfügbarkeit prüfen

E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer

Molecular cancer, 2018-08, Vol.17 (1), p.112-112, Article 112

2018

Link zum Volltext

Verfügbarkeit prüfen

Risk of stomach cancer in Aotearoa/New Zealand: A Māori population based case-control study

PloS one, 2017-07, Vol.12 (7), p.e0181581-e0181581

2017

Link zum Volltext

Verfügbarkeit prüfen

The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3

Cancer research (Chicago, Ill.), 2010-02, Vol.70 (4), p.1573-1584

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer

International journal of molecular sciences, 2019-10, Vol.20 (20), p.4980

2019

Link zum Volltext

Verfügbarkeit prüfen

Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking

Cancers, 2021-12, Vol.14 (1), p.102

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori

Familial cancer, 2019-01, Vol.18 (1), p.83-90

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(116)
Japanisch
(27)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early events in cell adhesion and polarity during epithelial-mesenchymal transition

Hereditary diffuse gastric cancer: A manifestation of lost cell polarity

Clinical spectrum and pleiotropic nature of CDH1 germline mutations

E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition

Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice

Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer

E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man

A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells

A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria

Hereditary gastric cancer: what’s new? Update 2013–2018

Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer

A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation

Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma

Modelling hereditary diffuse gastric cancer initiation using transgenic mouse‐derived gastric organoids and single‐cell sequencing

E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function

E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

Cohesin mutations are synthetic lethal with stimulation of WNT signaling

Comparison of Roche Cell-Free DNA collection Tubes® to Streck Cell-Free DNA BCT®s for sample stability using healthy volunteers

E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer

Risk of stomach cancer in Aotearoa/New Zealand: A Māori population based case-control study

The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3

Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer

Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking

Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori

Suchergebnisse filtern